The Texas Department of State Health Services (DSHS) has approved a broad definition of “incurable neurodegenerative disease,” a condition that now qualifies a patient to participate in the Texas Compassionate Use Program (T.CUP).
As of December 5, 2019, patients with the following diagnosis (and more than 100 others) may participate in our state’s low-THC medical cannabis program:
Alzheimer’s Disease and several forms of dementia, Parkinson’s Disease, several forms of muscular dystrophy, Huntington’s Disease, motor neuron diseases like ALS, multiple mitochondrial conditions, creatine disorders, and neurotransmitter defect.
Find a full list of the newly added conditions here.
Additionally, the rule allows “a treating physician of a patient suffering from an incurable neurodegenerative disease not listed… may submit a request to the department to have a disease added.”
More information about this new definition, the process by which it was approved, and resources for patients who’d like to participate can be found here.